Essential Premium

Light Street Stung by July Tech Rout, Still Tops Broader Market

But the Tiger Cub headed by Glen Kacher posted double-digit July losses as tech-focused hedge funds slumped, but both remain ahead of the S&P 500 and Nasdaq this year.

Alternatives in Wealth Management Forum | West Coast

September 29-30, 2026 | The Langham Huntington

Biotech IPO Fever Shows No Signs of Breaking

Deep Track and Cormorant are among the healthcare-focused investors backing three of the five biopharma companies slated to go public this week.

Sponsored

The Certainty of Uncertainty: Navigating the Shifting Private Landscape 

From the Archive: Data Sabotage Might Be the New Cyberattack

An asset manager’s doomsday scenario.

Related Content

Light Street Rockets Higher as Tech Bets Fuel 37 Percent Gain

Stephen Taub

Melvin Capital’s Comeback Plan

Stephen Taub

Light Street’s New Strategy Is Taking Hold

Stephen Taub

1270 Avenue of the Americas, Suite 1100

New York, NY 10020

 

© Institutional Investor, LLC. All material subject to strictly enforced copyright laws. Please read our Terms and Conditions and Privacy Policy before using the site. Institutional Investor is part of Delinian.

 

| Unsubscribe

LinkedIn
X (Twitter)
Bluesky
Instagram